Lutronic Vision to Present R:GEN™ Efficacy Data at 19th EURETINA Congress - Presentation to highlight results of R:GEN™ laser treatment from a clinical trial in patients with Central Serous Chorioretinopathy - BILLERICA, Mass., July 09, 2019 (GLOBE NEWSWIRE) -- Lutronic...

Lutronic Vision’s R:GEN™ Treats First CSC Patient at Seoul National University Hospital BILLERICA, Mass., June 17, 2019 (GLOBE NEWSWIRE) -- Lutronic Vision (“Lutronic” or the “Company”), a wholly-owned subsidiary of Lutronic Corporation, today announced that its R:GEN™ retina treatment...

Lutronic Vision Engages World Renowned Retina Expert for R:GEN™ Pilot AMD Clinical Study BILLERICA, Mass., March 26, 2019 (GLOBE NEWSWIRE) -- Lutronic Vision (“Lutronic” or “the Company”), a wholly-owned subsidiary of Lutronic Corporation, today announced that it has signed a memorandum...

Lutronic Vision Initiates Preclinical Trial of R:GEN™ Laser for the Treatment of Dry AMD BILLERICA, Mass., Jan. 29, 2019 (GLOBE NEWSWIRE) -- Lutronic Vision, a wholly-owned subsidiary of Lutronic Corporation, announced today that it has initiated a preclinical trial to determine the...